lobbying_activities: 3234280

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3234280	168d625f-d2f9-4dc8-a36a-6fc2e4432254	Q3	LMH STRATEGIC SOLUTIONS	401108183	AVADEL PHARMACEUTICALS, PLC	2024	third_quarter	PHA	Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2024-10-09T14:52:45-04:00